Total: £ 56.28
Published Date: 2026-03-30 | Pages: 138 | Tables: 126 | Medical Care
The global High-Throughput Screening Services for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The North American market for High-Throughput Screening Services for Drug Discovery is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for High-Throughput Screening Services for Drug Discovery is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for High-Throughput Screening Services for Drug Discovery in Pharmaceutical Company is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of High-Throughput Screening Services for Drug Discovery include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global High-Throughput Screening Services for Drug Discovery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding High-Throughput Screening Services for Drug Discovery. The High-Throughput Screening Services for Drug Discovery market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global High-Throughput Screening Services for Drug Discovery market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist High-Throughput Screening Services for Drug Discovery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
Segment by Type
Chemical-based HTS Assays
Biological-based HTS Assays
Cell-based HTS Assays
Genetic-based HTS Assays
Segment by Application
Pharmaceutical Company
Biotechnology Company
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for High-Throughput Screening Services for Drug Discovery companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chemical-based HTS Assays
1.2.3 Biological-based HTS Assays
1.2.4 Cell-based HTS Assays
1.2.5 Genetic-based HTS Assays
1.3 Market by Application
1.3.1 Global High-Throughput Screening Services for Drug Discovery Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-Throughput Screening Services for Drug Discovery Market Perspective (2021–2032)
2.2 Global High-Throughput Screening Services for Drug Discovery Growth Trends by Region
2.2.1 Global High-Throughput Screening Services for Drug Discovery Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 High-Throughput Screening Services for Drug Discovery Historic Market Size by Region (2021–2026)
2.2.3 High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Region (2027–2032)
2.3 High-Throughput Screening Services for Drug Discovery Market Dynamics
2.3.1 High-Throughput Screening Services for Drug Discovery Industry Trends
2.3.2 High-Throughput Screening Services for Drug Discovery Market Drivers
2.3.3 High-Throughput Screening Services for Drug Discovery Market Challenges
2.3.4 High-Throughput Screening Services for Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-Throughput Screening Services for Drug Discovery Players by Revenue
3.1.1 Global Top High-Throughput Screening Services for Drug Discovery Players by Revenue (2021–2026)
3.1.2 Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Players (2021–2026)
3.2 Global Top High-Throughput Screening Services for Drug Discovery Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by High-Throughput Screening Services for Drug Discovery Revenue
3.4 Global High-Throughput Screening Services for Drug Discovery Market Concentration Ratio
3.4.1 Global High-Throughput Screening Services for Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-Throughput Screening Services for Drug Discovery Revenue in 2025
3.5 Global Key Players of High-Throughput Screening Services for Drug Discovery Head Offices and Areas Served
3.6 Global Key Players of High-Throughput Screening Services for Drug Discovery, Products and Applications
3.7 Global Key Players of High-Throughput Screening Services for Drug Discovery, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 High-Throughput Screening Services for Drug Discovery Breakdown Data by Type
4.1 Global High-Throughput Screening Services for Drug Discovery Historic Market Size by Type (2021–2026)
4.2 Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Type (2027–2032)
5 High-Throughput Screening Services for Drug Discovery Breakdown Data by Application
5.1 Global High-Throughput Screening Services for Drug Discovery Historic Market Size by Application (2021–2026)
5.2 Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
6.2 North America High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
6.4 North America High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
7.2 Europe High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
7.4 Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
8.2 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (2021–2026)
8.4 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
9.2 Latin America High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
9.4 Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
10.2 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
10.4 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.1.5 Eurofins Discovery Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Introduction
11.2.4 Charles River Laboratories Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.2.5 Charles River Laboratories Recent Development
11.3 Axcelead
11.3.1 Axcelead Company Details
11.3.2 Axcelead Business Overview
11.3.3 Axcelead High-Throughput Screening Services for Drug Discovery Introduction
11.3.4 Axcelead Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.3.5 Axcelead Recent Development
11.4 NUVISAN
11.4.1 NUVISAN Company Details
11.4.2 NUVISAN Business Overview
11.4.3 NUVISAN High-Throughput Screening Services for Drug Discovery Introduction
11.4.4 NUVISAN Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.4.5 NUVISAN Recent Development
11.5 Axxam S.p.A.
11.5.1 Axxam S.p.A. Company Details
11.5.2 Axxam S.p.A. Business Overview
11.5.3 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Introduction
11.5.4 Axxam S.p.A. Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.5.5 Axxam S.p.A. Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec High-Throughput Screening Services for Drug Discovery Introduction
11.6.4 Evotec Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.6.5 Evotec Recent Development
11.7 Selvita
11.7.1 Selvita Company Details
11.7.2 Selvita Business Overview
11.7.3 Selvita High-Throughput Screening Services for Drug Discovery Introduction
11.7.4 Selvita Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.7.5 Selvita Recent Development
11.8 Azenta Life Sciences
11.8.1 Azenta Life Sciences Company Details
11.8.2 Azenta Life Sciences Business Overview
11.8.3 Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Introduction
11.8.4 Azenta Life Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.8.5 Azenta Life Sciences Recent Development
11.9 Bienta (Enamine)
11.9.1 Bienta (Enamine) Company Details
11.9.2 Bienta (Enamine) Business Overview
11.9.3 Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Introduction
11.9.4 Bienta (Enamine) Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.9.5 Bienta (Enamine) Recent Development
11.10 Cayman Chemical
11.10.1 Cayman Chemical Company Details
11.10.2 Cayman Chemical Business Overview
11.10.3 Cayman Chemical High-Throughput Screening Services for Drug Discovery Introduction
11.10.4 Cayman Chemical Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.10.5 Cayman Chemical Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs High-Throughput Screening Services for Drug Discovery Introduction
11.11.4 Creative Biolabs Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Creative Bioarray
11.12.1 Creative Bioarray Company Details
11.12.2 Creative Bioarray Business Overview
11.12.3 Creative Bioarray High-Throughput Screening Services for Drug Discovery Introduction
11.12.4 Creative Bioarray Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.12.5 Creative Bioarray Recent Development
11.13 BOC Sciences
11.13.1 BOC Sciences Company Details
11.13.2 BOC Sciences Business Overview
11.13.3 BOC Sciences High-Throughput Screening Services for Drug Discovery Introduction
11.13.4 BOC Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.13.5 BOC Sciences Recent Development
11.14 MEDICILON
11.14.1 MEDICILON Company Details
11.14.2 MEDICILON Business Overview
11.14.3 MEDICILON High-Throughput Screening Services for Drug Discovery Introduction
11.14.4 MEDICILON Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.14.5 MEDICILON Recent Development
11.15 Domainex
11.15.1 Domainex Company Details
11.15.2 Domainex Business Overview
11.15.3 Domainex High-Throughput Screening Services for Drug Discovery Introduction
11.15.4 Domainex Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.15.5 Domainex Recent Development
11.16 Creative Diagnostics
11.16.1 Creative Diagnostics Company Details
11.16.2 Creative Diagnostics Business Overview
11.16.3 Creative Diagnostics High-Throughput Screening Services for Drug Discovery Introduction
11.16.4 Creative Diagnostics Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.16.5 Creative Diagnostics Recent Development
11.17 Multispan
11.17.1 Multispan Company Details
11.17.2 Multispan Business Overview
11.17.3 Multispan High-Throughput Screening Services for Drug Discovery Introduction
11.17.4 Multispan Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.17.5 Multispan Recent Development
11.18 AntalGenics
11.18.1 AntalGenics Company Details
11.18.2 AntalGenics Business Overview
11.18.3 AntalGenics High-Throughput Screening Services for Drug Discovery Introduction
11.18.4 AntalGenics Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.18.5 AntalGenics Recent Development
11.19 Creative Biostructure
11.19.1 Creative Biostructure Company Details
11.19.2 Creative Biostructure Business Overview
11.19.3 Creative Biostructure High-Throughput Screening Services for Drug Discovery Introduction
11.19.4 Creative Biostructure Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.19.5 Creative Biostructure Recent Development
11.20 BPS Bioscience
11.20.1 BPS Bioscience Company Details
11.20.2 BPS Bioscience Business Overview
11.20.3 BPS Bioscience High-Throughput Screening Services for Drug Discovery Introduction
11.20.4 BPS Bioscience Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.20.5 BPS Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Chemical-based HTS Assays
Table 3. Key Players of Biological-based HTS Assays
Table 4. Key Players of Cell-based HTS Assays
Table 5. Key Players of Genetic-based HTS Assays
Table 6. Global High-Throughput Screening Services for Drug Discovery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million), 2021–2026
Table 9. Global High-Throughput Screening Services for Drug Discovery Market Share by Region (2021–2026)
Table 10. Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global High-Throughput Screening Services for Drug Discovery Market Share by Region (2027–2032)
Table 12. High-Throughput Screening Services for Drug Discovery Market Trends
Table 13. High-Throughput Screening Services for Drug Discovery Market Drivers
Table 14. High-Throughput Screening Services for Drug Discovery Market Challenges
Table 15. High-Throughput Screening Services for Drug Discovery Market Restraints
Table 16. Global High-Throughput Screening Services for Drug Discovery Revenue by Players (US$ Million), 2021–2026
Table 17. Global High-Throughput Screening Services for Drug Discovery Market Share by Players (2021–2026)
Table 18. Global Top High-Throughput Screening Services for Drug Discovery Players by Tier (Tier 1, Tier 2, and Tier 3), based on High-Throughput Screening Services for Drug Discovery Revenue, 2025
Table 19. Ranking of Global Top High-Throughput Screening Services for Drug Discovery Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by High-Throughput Screening Services for Drug Discovery Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of High-Throughput Screening Services for Drug Discovery, Headquarters and Area Served
Table 22. Global Key Players of High-Throughput Screening Services for Drug Discovery, Products and Applications
Table 23. Global Key Players of High-Throughput Screening Services for Drug Discovery, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global High-Throughput Screening Services for Drug Discovery Market Size by Type (US$ Million), 2021–2026
Table 26. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Type (2021–2026)
Table 27. Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Type (2027–2032)
Table 29. Global High-Throughput Screening Services for Drug Discovery Market Size by Application (US$ Million), 2021–2026
Table 30. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Application (2021–2026)
Table 31. Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Application (2027–2032)
Table 33. North America High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 35. North America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 36. Europe High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 38. Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
Table 48. Eurofins Discovery Company Details
Table 49. Eurofins Discovery Business Overview
Table 50. Eurofins Discovery High-Throughput Screening Services for Drug Discovery Product
Table 51. Eurofins Discovery Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 52. Eurofins Discovery Recent Development
Table 53. Charles River Laboratories Company Details
Table 54. Charles River Laboratories Business Overview
Table 55. Charles River Laboratories High-Throughput Screening Services for Drug Discovery Product
Table 56. Charles River Laboratories Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 57. Charles River Laboratories Recent Development
Table 58. Axcelead Company Details
Table 59. Axcelead Business Overview
Table 60. Axcelead High-Throughput Screening Services for Drug Discovery Product
Table 61. Axcelead Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 62. Axcelead Recent Development
Table 63. NUVISAN Company Details
Table 64. NUVISAN Business Overview
Table 65. NUVISAN High-Throughput Screening Services for Drug Discovery Product
Table 66. NUVISAN Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 67. NUVISAN Recent Development
Table 68. Axxam S.p.A. Company Details
Table 69. Axxam S.p.A. Business Overview
Table 70. Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Product
Table 71. Axxam S.p.A. Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 72. Axxam S.p.A. Recent Development
Table 73. Evotec Company Details
Table 74. Evotec Business Overview
Table 75. Evotec High-Throughput Screening Services for Drug Discovery Product
Table 76. Evotec Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 77. Evotec Recent Development
Table 78. Selvita Company Details
Table 79. Selvita Business Overview
Table 80. Selvita High-Throughput Screening Services for Drug Discovery Product
Table 81. Selvita Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 82. Selvita Recent Development
Table 83. Azenta Life Sciences Company Details
Table 84. Azenta Life Sciences Business Overview
Table 85. Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Product
Table 86. Azenta Life Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 87. Azenta Life Sciences Recent Development
Table 88. Bienta (Enamine) Company Details
Table 89. Bienta (Enamine) Business Overview
Table 90. Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Product
Table 91. Bienta (Enamine) Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 92. Bienta (Enamine) Recent Development
Table 93. Cayman Chemical Company Details
Table 94. Cayman Chemical Business Overview
Table 95. Cayman Chemical High-Throughput Screening Services for Drug Discovery Product
Table 96. Cayman Chemical Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 97. Cayman Chemical Recent Development
Table 98. Creative Biolabs Company Details
Table 99. Creative Biolabs Business Overview
Table 100. Creative Biolabs High-Throughput Screening Services for Drug Discovery Product
Table 101. Creative Biolabs Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 102. Creative Biolabs Recent Development
Table 103. Creative Bioarray Company Details
Table 104. Creative Bioarray Business Overview
Table 105. Creative Bioarray High-Throughput Screening Services for Drug Discovery Product
Table 106. Creative Bioarray Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 107. Creative Bioarray Recent Development
Table 108. BOC Sciences Company Details
Table 109. BOC Sciences Business Overview
Table 110. BOC Sciences High-Throughput Screening Services for Drug Discovery Product
Table 111. BOC Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 112. BOC Sciences Recent Development
Table 113. MEDICILON Company Details
Table 114. MEDICILON Business Overview
Table 115. MEDICILON High-Throughput Screening Services for Drug Discovery Product
Table 116. MEDICILON Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 117. MEDICILON Recent Development
Table 118. Domainex Company Details
Table 119. Domainex Business Overview
Table 120. Domainex High-Throughput Screening Services for Drug Discovery Product
Table 121. Domainex Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 122. Domainex Recent Development
Table 123. Creative Diagnostics Company Details
Table 124. Creative Diagnostics Business Overview
Table 125. Creative Diagnostics High-Throughput Screening Services for Drug Discovery Product
Table 126. Creative Diagnostics Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 127. Creative Diagnostics Recent Development
Table 128. Multispan Company Details
Table 129. Multispan Business Overview
Table 130. Multispan High-Throughput Screening Services for Drug Discovery Product
Table 131. Multispan Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 132. Multispan Recent Development
Table 133. AntalGenics Company Details
Table 134. AntalGenics Business Overview
Table 135. AntalGenics High-Throughput Screening Services for Drug Discovery Product
Table 136. AntalGenics Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 137. AntalGenics Recent Development
Table 138. Creative Biostructure Company Details
Table 139. Creative Biostructure Business Overview
Table 140. Creative Biostructure High-Throughput Screening Services for Drug Discovery Product
Table 141. Creative Biostructure Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 142. Creative Biostructure Recent Development
Table 143. BPS Bioscience Company Details
Table 144. BPS Bioscience Business Overview
Table 145. BPS Bioscience High-Throughput Screening Services for Drug Discovery Product
Table 146. BPS Bioscience Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
Table 147. BPS Bioscience Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. High-Throughput Screening Services for Drug Discovery Picture
Figure 2. Global High-Throughput Screening Services for Drug Discovery Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global High-Throughput Screening Services for Drug Discovery Market Share by Type: 2025 vs 2032
Figure 4. Chemical-based HTS Assays Features
Figure 5. Biological-based HTS Assays Features
Figure 6. Cell-based HTS Assays Features
Figure 7. Genetic-based HTS Assays Features
Figure 8. Global High-Throughput Screening Services for Drug Discovery Market Size by Application (US$ Million), 2021–2032
Figure 9. Global High-Throughput Screening Services for Drug Discovery Market Share by Application: 2025 vs 2032
Figure 10. Pharmaceutical Company Case Studies
Figure 11. Biotechnology Company Case Studies
Figure 12. High-Throughput Screening Services for Drug Discovery Report Years Considered
Figure 13. Global High-Throughput Screening Services for Drug Discovery Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global High-Throughput Screening Services for Drug Discovery Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global High-Throughput Screening Services for Drug Discovery Market Share by Region: 2025 vs 2032
Figure 16. Global High-Throughput Screening Services for Drug Discovery Market Share by Players in 2025
Figure 17. Global High-Throughput Screening Services for Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by High-Throughput Screening Services for Drug Discovery Revenue in 2025
Figure 19. North America High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
Figure 21. United States High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
Figure 25. Germany High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Share by Region (2021–2032)
Figure 33. China High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
Figure 41. Mexico High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
Figure 45. Israel High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Eurofins Discovery Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 49. Charles River Laboratories Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 50. Axcelead Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 51. NUVISAN Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 52. Axxam S.p.A. Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 53. Evotec Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 54. Selvita Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 55. Azenta Life Sciences Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 56. Bienta (Enamine) Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 57. Cayman Chemical Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 58. Creative Biolabs Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 59. Creative Bioarray Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 60. BOC Sciences Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 61. MEDICILON Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 62. Domainex Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 63. Creative Diagnostics Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 64. Multispan Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 65. AntalGenics Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 66. Creative Biostructure Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 67. BPS Bioscience Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed